| Market Cap | ₹796Cr |
| ROE | 14.72% |
| P/E Ratio(TTM) | 33.96 |
| EPS(TTM) | 49.65 |
| P/B Ratio | 5.63 |
| Dividend Yield | 0.04% |
| Industry P/E | 41.00 |
| Book Value | 299.47 |
| Debt to Equity | 1.18 |
| Face Value | 10 |
| Parent Organisation | Fredun Pharmaceuticals Ltd |
| Managing Director | Mr. Fredun Medhora |
| BSE Symbol | 539730 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.85 | ||
| Gland Pharma | NA (0.00%) | 40.72 | ||
| Ajanta Pharma | NA (0.00%) | 33.06 | ||
| Eris Lifesciences | NA (0.00%) | 53.97 |